Fisher Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.3M Buy
732,872
+67,785
+10% +$1.62M 0.01% 346
2025
Q4
$17.8M Buy
665,087
+26,595
+4% +$636K 0.01% 340
2025
Q3
$13.6M Buy
638,492
+328,181
+106% +$7.76M ﹤0.01% 373
2025
Q2
$6.69M Sell
310,311
-44,710
-13% -$831K ﹤0.01% 447
2025
Q1
$5.9M Buy
355,021
+27,516
+8% +$500K ﹤0.01% 471
2024
Q4
$6.01M Buy
327,505
+132,906
+68% +$2.15M ﹤0.01% 480
2024
Q3
$2.99M Buy
194,599
+31,980
+20% +$534K ﹤0.01% 536
2024
Q2
$2.64M Buy
162,619
+9,689
+6% +$156K ﹤0.01% 550
2024
Q1
$2.83M Buy
152,930
+9,876
+7% +$245K ﹤0.01% 556
2023
Q4
$4.48M Buy
+143,054
New +$3.42M ﹤0.01% 503

Other funds holding ACAD